CM Life Sciences Inc

CM Life Sciences Inc., trading under the ticker CMLF, is a special purpose acquisition company sponsored by CM Life Sciences, the SPAC platform affiliated with Cowen Inc., and focused on the healthcare and life sciences sector. The company completed its IPO in 2021 and, as of a DEFM14A proxy filing submitted to the SEC on March 31, 2022, was in an advanced stage of a proposed business combination, having distributed a definitive merger proxy to shareholders for approval. The DEFM14A filing, carrying accession number 0001628280-22-008073, reflects the company's formal shareholder vote process ahead of a potential closing. Subscribers can access the full filing history, deal timeline, and sponsor background for CMLF on SpacDesk — sign up today for complete data coverage.